Skip to main content
Lindsay Rosenwald, MD, Family Medicine, New York, NY

LindsayRosenwaldMD

Family Medicine • New York, NY

Physician

Join to view full profile

Dr. Rosenwald is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Rosenwald's full profile

Already have an account?

  • Office

    787 7th Ave
    New York, NY 10019
    Phone+1 212-554-4366

Education & Training

  • Abington Memorial Hospital
    Abington Memorial HospitalInternship, Internal Medicine, 1983 - 1984
  • Lewis Katz School of Medicine at Temple University
    Lewis Katz School of Medicine at Temple UniversityClass of 1983

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 1990 - 2027
  • PA State Medical License
    PA State Medical License 1983 - 2010

Press Mentions

  • Avenue Therapeutics Enters into a Transformational License Agreement with AnnJi Pharmaceutical to Develop and Commercialize AJ201, a First-in-Class Clinical Asset for the Treatment of Spinal and Bulbar Muscular Atrophy
    Avenue Therapeutics Enters into a Transformational License Agreement with AnnJi Pharmaceutical to Develop and Commercialize AJ201, a First-in-Class Clinical Asset for the Treatment of Spinal and Bulbar Muscular AtrophyMarch 3rd, 2023
  • Study Published in American Journal of Hematology Demonstrates First Reported Evidence of Safe and Successful Boosting of Cytomegalovirus Vaccine-Specific T Cell Immunity in a Stem Cell Transplant Recipient via Vaccination of a Donor with Triplex
    Study Published in American Journal of Hematology Demonstrates First Reported Evidence of Safe and Successful Boosting of Cytomegalovirus Vaccine-Specific T Cell Immunity in a Stem Cell Transplant Recipient via Vaccination of a Donor with TriplexFebruary 15th, 2023
  • Fortress Biotech Announces Receipt of Notice of Option Exercise from AstraZeneca to Fully Acquire Caelum Biosciences, a Company Founded by Fortress Biotech
    Fortress Biotech Announces Receipt of Notice of Option Exercise from AstraZeneca to Fully Acquire Caelum Biosciences, a Company Founded by Fortress BiotechSeptember 29th, 2021
  • Join now to see all

Dr. Lindsay Rosenwald, Dr. Lindsay Rosenwald, MD, Dr. L Rosenwald